Clinical trial
A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse…
NCT00396747 · Université Catholique de Louvain, Other · Completed
Key facts
| NCT number | NCT00396747 |
|---|---|
| Title | A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study |
| Official title | Phase IV Study of Early RA: a Randomized Magnetic Resonance Imaging Study Comparing the Effects of Methotrexate Alone or in Combination With Infliximab or Intravenous Pulse Methylprednisolone |
| Lead sponsor | Université Catholique de Louvain, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Infliximab, methylprednisolone, methotrexate, Methotrexate, Methotrexate + Methylprednisolone, Methotrexate + Infliximab |
| Enrollment | 45 |
| Start date | Jun 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Nov 7, 2006 |
| Last update posted | Oct 19, 2007 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: